Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

HUANG Jin, LIU Jingxue, ZENG Ying, YUAN Fang. Transient receptor potential type vanilloid 1 regulates EGFR related functions in pancreatic cancer cells[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 126-130. doi: 10.3969/j.issn.1006-0111.2018.02.007
Citation: HUANG Jin, LIU Jingxue, ZENG Ying, YUAN Fang. Transient receptor potential type vanilloid 1 regulates EGFR related functions in pancreatic cancer cells[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 126-130. doi: 10.3969/j.issn.1006-0111.2018.02.007

Transient receptor potential type vanilloid 1 regulates EGFR related functions in pancreatic cancer cells

doi: 10.3969/j.issn.1006-0111.2018.02.007
  • Received Date: 2017-12-01
  • Rev Recd Date: 2018-01-04
  • Objective To evaluate the regulation of the TRPV1 receptor on the expression of EGFR protein and the effects on related cell functions. Methods Human pancreatic cancer cells PANC-1 were cultured and treated by over-expression and siRNA. Cell proliferations were detected by CCK-8 experiment. RT-PCR test was used to detect the expression of oncogenes Akt2 and K-ras. Results EGFR protein was down-regulated by TRPV1 over-expression or by agonist activation in pancreatic cancer cells. EGFR protein was increased by the interference of TRPV1 expression. The proliferation rate of pancreatic cancer cells was decreased and Akt2, K-ras were significantly inhibited by TRPV1 over-expressing. Conclusion The expression of TRPV1 in pancreatic cancer cells regulated the EGFR protein content. The cell proliferation and oncogene expression were inhibited by TRPV1 over-expressing.
  • [1] Siegel RL,Miller KD,Jemal A. Cancer statistics,2017[J]. CA Cancer J Clin,2017,67(1):7-30.
    [2] Miller KD,Siegel RL,Lin CC,et al. Cancer treatment and survivorship statistics,2016[J]. CA Cancer J Clin,2016,66(4):271-289.
    [3] 王正航,周军,沈琳. 胰腺癌药物治疗的现状与困境[J]. 中华肿瘤杂志,2017,39(9):712-716.
    [4] Voets T,Droogmans G,Wissenbach U,et al. The principle of temperature-dependent gating in cold-and heat-sensitive TRP channels[J]. Nature,2004,430(7001):748-754.
    [5] Kym PR,Kort ME,Hutchins CW. Analgesic potential of TRPV1 antagonists[J]. Biochem Pharmacol,2009,78(3):211-216.
    [6] Wong GY,Gavva NR. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics:Recent advances and setbacks[J]. Brain Res Rev,2009,60(1):267-277.
    [7] Prevarskaya N,Zhang L,Barritt G. TRP channels in cancer[J]. Biochim Biophys Acta, 2007,1772(8):937-946.
    [8] Drewes AM,Krarup AL,Detlefsen S,et al. Pain in chronic pancreatitis:the role of neuropathic pain mechanisms[J]. Gut,2008,57(11):1616-1627.
    [9] Zheng L,Chen J,Ma Z,et al. Capsaicin enhances anti-proliferation efficacy of pirarubicin via activating TRPV1 and inhibiting PCNA nuclear translocation in 5637 cells[J]. Mol Med Rep,2016,13(1):881-887.
    [10] Wu TT,Peters AA,Tan PT,et al. Consequences of activating the calcium-permeable ion channel TRPV1 in breast cancer cells with regulated TRPV1 expression[J]. Cell Calcium,2014,56(2):59-67.
    [11] Miao X,Liu G,Xu X,et al. High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma[J]. Cancer Genet Cytogenet,2008,186(1):25-32.
    [12] Lazzeri M,Vannucchi MG,Spinelli M,et al. Transient receptor potential vanilloid type 1(TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder[J]. Eur Urol,2005,48(4):691-698.
    [13] Bode AM, Cho YY, Zheng D,et al. Transient receptor potential type vanilloid 1 suppresses skin carcinogenesis[J].Cancer Res,2009,69(3):905-913.
  • 加载中
通讯作者: 陈斌, [email protected]
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(3275) PDF downloads(834) Cited by()

Related
Proportional views

Transient receptor potential type vanilloid 1 regulates EGFR related functions in pancreatic cancer cells

doi: 10.3969/j.issn.1006-0111.2018.02.007

Abstract: Objective To evaluate the regulation of the TRPV1 receptor on the expression of EGFR protein and the effects on related cell functions. Methods Human pancreatic cancer cells PANC-1 were cultured and treated by over-expression and siRNA. Cell proliferations were detected by CCK-8 experiment. RT-PCR test was used to detect the expression of oncogenes Akt2 and K-ras. Results EGFR protein was down-regulated by TRPV1 over-expression or by agonist activation in pancreatic cancer cells. EGFR protein was increased by the interference of TRPV1 expression. The proliferation rate of pancreatic cancer cells was decreased and Akt2, K-ras were significantly inhibited by TRPV1 over-expressing. Conclusion The expression of TRPV1 in pancreatic cancer cells regulated the EGFR protein content. The cell proliferation and oncogene expression were inhibited by TRPV1 over-expressing.

HUANG Jin, LIU Jingxue, ZENG Ying, YUAN Fang. Transient receptor potential type vanilloid 1 regulates EGFR related functions in pancreatic cancer cells[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 126-130. doi: 10.3969/j.issn.1006-0111.2018.02.007
Citation: HUANG Jin, LIU Jingxue, ZENG Ying, YUAN Fang. Transient receptor potential type vanilloid 1 regulates EGFR related functions in pancreatic cancer cells[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 126-130. doi: 10.3969/j.issn.1006-0111.2018.02.007
Reference (13)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return